Web-based Cognitive Behavioral Treatment for Insomnia in Dementia Caregivers
Part of paid clinical trials in Columbia, Missouri.
- Sponsor
- University of South Florida
- Study ID
- NCT04632628
- Status
- Recruiting
Conditions
- Dementia
- Insomnia Chronic
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Web-based Cognitive Behavior Therapy for Insomnia (CBT-I) — BEHAVIORALParticipants will complete 4 web-based CBT- I sessions. Lesson 1: Sleep Hygiene and Stimulus Control Lesson 2: Sleep Restriction and Relaxation Strategies Lesson 3: Identifying and Restructuring Dysfunction Thoughts Lesson 4: Practical Recommendations, Review, and Maintenance of Change
Study Details
Over the next 30 years, more than 10 million persons living with dementia in the United States will receive care at home from an unpaid and untrained family caregiver. At home care is preferred by caregivers and persons with dementia alike, but increases the caregiver's risk of insomnia and related negative health outcomes, including depression, anxiety, cognitive disturbances and poor quality of life. Cognitive behavioral therapy for insomnia (CBT-I) is a highly effective and established evidence based treatment for adults of all ages. Although relatively understudied in dementia caregivers, the research by our group and others suggests CBT-I is also efficacious in caregivers. Our team developed a brief (4 session) CBT-I protocol specifically adapted for dementia caregivers (CBT-I) and has shown in person and remote (i.e. telehealth) delivery of this protocol significantly reduces insomnia symptoms and improves mood (moderate to large effects). Given demands on caregivers' time and limited availability of trained CBT-I providers, a web-based version of CBT-I (WebCBT-I; the online treatment will be called NiteCAPP) is needed to increase the accessibility of this efficacious treatment. WebCBT-I will allow for flexible at home scheduling, and the skills needed to monitor caregiver treatment progress can be quickly and efficiently taught to healthcare providers. The overarching goal of this project is to develop and test WebCBT-I in caregivers of persons with dementia. Objectives 1. To examine the clinical and health characteristics, including sleep, pain, fatigue, cognitive abilities, and cardiovascular health in dementia caregivers with insomnia. 2. To examine changes in the primary clinical outcomes, including complaints of poor sleep, and fatigue. 3. To examine changes in the secondary clinical outcomes, including mood, daytime functioning, cognitive functioning, and cardiovascular health. 4. To examine the mechanistic variables, including arousal (heart rate variability, HRV).
Key Dates
- Start date
- Nov 14, 2023
- Status verified
- Mar 2025
- Primary completion
- Mar 31, 2026
- Completion
- Mar 31, 2027
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: NiteCAPP: Online Cognitive Behavioral Therapy for InsomniaThis is a pilot trial with one treatment condition (CBT-I).
Primary Outcome Measure
Daily Electronic Sleep and Pain Diaries - Sleep Onset Latency [ Time Frame: 6 weeks ]
Central Contacts
- Christina S McCrae573-882-0982
- Riley Stephens573-882-8881
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Missouri | Columbia | Missouri | 65212 | Christina McCrae Riley Stephens |
Find similar trials in Columbia, MO
Related Studies
- Trial-Ready Cohort-Down Syndrome (TRC-DS)Recruiting · University of Southern California · Phoenix, Arizona
- Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older AdultsPHASE4 · Recruiting · Duke University · Birmingham, Alabama
- Targeting Insomnia in School Aged Children With Autism Spectrum DisorderRecruiting · University of Missouri-Columbia · Columbia, Missouri
- A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic MutationPHASE2/PHASE3 · Recruiting · Washington University School of Medicine · Birmingham, Alabama